Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 06, 2018 08:00 ET | Source: Delcath Systems, Inc.

Delcath Announces Commencement of Rights Offering Subscription Period

NEW YORK, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces the...
July 31, 2018 08:00 ET | Source: Delcath Systems, Inc.

Summary of Calendar for Upcoming Proposed Delcath Rights Offering

NEW YORK, July 31, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, reminds...
July 27, 2018 08:00 ET | Source: Delcath Systems, Inc.

Delcath Amends Phase 3 Ocular Melanoma Trial Protocol

Revision to Nonrandomized (Single Arm) Study Reduces Trial Size Enrollment Requirement Enrollment Anticipated to be Completed by First Half 2019 NEW YORK, July 27, 2018 (GLOBE NEWSWIRE) --...
July 16, 2018 08:00 ET | Source: Delcath Systems, Inc.

Delcath Systems Announces Rights Offering and Backstop Commitment Ownership Date of August 1, 2018

NEW YORK, July 16, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced...
July 09, 2018 08:00 ET | Source: Delcath Systems, Inc.

Delcath Announces 100th Commercial CHEMOSAT Treatment Completed at Leiden University Medical Center, The Netherlands

NEW YORK, July 09, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces...
May 29, 2018 08:30 ET | Source: Delcath Systems, Inc.

Delcath Systems to Present at the 8th Annual LD Micro Invitational

NEW YORK, May 29, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced...
May 22, 2018 08:15 ET | Source: Delcath Systems, Inc.

Delcath Sponsors Looking For A Cure Ocular Melanoma Charity Event

NEW YORK, May 22, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, is proud to...
May 16, 2018 08:00 ET | Source: Delcath Systems, Inc.

Delcath’s CHEMOSAT Included in German Treatment Guidelines for Melanoma Liver Metastases

NEW YORK, May 16, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that...
May 14, 2018 08:00 ET | Source: Delcath Systems, Inc.

Delcath’s PHP Therapy Featured in Video Learning Session at the European Conference of Interventional Oncology

NEW YORK, May 14, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that...
May 10, 2018 08:00 ET | Source: Delcath Systems, Inc.

Delcath Announces First Quarter 2018 Financial Results

NEW YORK, May 10, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology Company focused on the treatment of primary and metastatic liver cancers, announces...